Pelvic mesh is a medical device that is commonly used in the treatment of Pelvic Organ Prolapse (“POP”) or Stress Urinary Incontinence (“SUI”). The mesh is surgically implanted into the vaginal and/or pelvic region of the body to support weakened or damaged tissue.
Although some women experience a good long-term outcome after surgery, there are many women that suffer severe, life-changing complications. This includes chronic pain, mesh exposure or erosion, vaginal scarring, recurring urinary tract infections and pain during intercourse.
Due to the structural design of the mesh, bodily tissue grows through the mesh pores after it has been implanted. This renders it nearly impossible to successfully extract the entire mesh device at a later stage, as the mesh and the tissue becomes fused. The women affected by these complications often undergo multiple surgeries in an attempt to have the mesh partially explanted or to treat some of the symptoms they experience.
RH Lawyers Inc. (“RHL”) and Richard Spoor Inc. (“RSI”) have launched class action proceedings against Johnson & Johnson, Coloplast and various other associated manufacturers and distributors of pelvic mesh, on the basis that the pelvic mesh devices were defective. The class action seeks to claim for compensation on behalf of class members who were implanted with the mesh, for the harm they suffered as a result.
